Skip to main content
. 2018 Jun 28;2018(6):CD012721. doi: 10.1002/14651858.CD012721.pub2

Wang 2010.

Methods Study design: parallel, individual, RCT
Centres: 1, Taiwan
Start of enrolment: not reported
End of enrolment: not reported
Follow‐up: at least 3 months
Run‐in period: not reported
Participants Inclusion criteria: "hypertensive pts who had DHF, defined as the presence of HF signs/symptoms, diastolic dysfunction (mitral annular early diastolic velocity (E') < 8 cm/s), and left ventricular (LV) ejection fraction (EF) > 50%"
Exclusion criteria: not reported
Randomised (N): 36 (19 intervention, 17 control)
Withdrawn (N): not reported
Lost to follow‐up (N): not reported
Analysed (N): not reported
Age (years, mean, SD): not reported
Sex (% men): not reported
Ethnicity (%): not reported
Systolic blood pressure not reported
Heart rate not reported
BMI not reported
Serum creatinine not reported
B‐type natriuretic peptide not reported
NT pro B‐type natriuretic peptide not reported
LVEF (%, mean, SD): intervention: 67, 7; control: 66, 7
NYHA class not reported
Hypertension not reported
Diabetes not reported
Atrial fibrillation not reported
Hospitalisation for heart failure: not reported
Coronary heart disease not reported
Stroke not reported
Diuretic not reported
Digoxin not reported
Beta‐blocker not reported
ACEI not reported
ARB not reported
MRA study drug
Interventions Intervention: spironolactone. 50 mg/d
Comparator: no treatment control
Concomitant medication: not reported
Outcomes Planned: we are not aware of a published protocol or pre‐registered clinical trial registry entry
Reported: echo‐parameters, systolic myocardial velocities
Notes does not contribute outcome data to this review
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk not reported
Allocation concealment (selection bias) Unclear risk not reported
Blinding of participants and personnel (performance bias) 
 All outcomes Unclear risk not reported
Blinding of outcome assessment (detection bias) 
 All outcomes Unclear risk not reported
Incomplete outcome data (attrition bias) 
 All outcomes Unclear risk not reported
Selective reporting (reporting bias) Unclear risk unable to assess
Other bias Unclear risk funding not reported